On Target Laboratories Secures $30 Million For Commercialization Of Cytalux® (Pafolacianine) Injection
Amount Raised
$30 Million
Round Type
Funding Round
West LafayetteBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the completion of a $30 million Series C financing. This significant investment will play a pivotal role in accelerating the commercialization of the company's novel compound, CYTALUX, the only FDA approved molecular imaging agent that illuminates lung and ovarian cancer as an adjunct during surgery, enabling surgeons to detect more cancer for resection.
Quick answer
On Target Laboratories raised $30 Million in a Funding Round round, dated November 16, 2023. Investors: Centers For Medicare & Medicaid Services. On Target Laboratories is based in West Lafayette, Indiana, United States.
- How much did On Target Laboratories raise?
- On Target Laboratories raised $30 Million in a Funding Round round on November 16, 2023.
- Who invested in On Target Laboratories?
- Centers For Medicare & Medicaid Services is named as investors in this round.
- What does On Target Laboratories do?
- On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery.
- Where is On Target Laboratories based and how big is it?
- On Target Laboratories is based in West Lafayette, Indiana, United States.
- Who are the decision-makers at On Target Laboratories?
- Fundz holds 1 contact at On Target Laboratories. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as On Target Laboratories that raised within 45 days of this round, from Fundz verified event records.
- MAIA Biotechnology raised $4.9M (Seed) on November 15, 2023.
- EyeBio raised an undisclosed amount (Series A) on November 14, 2023.
- MBrace Therapeutics raised $85M (Series B) on November 14, 2023.
- Ascidian Therapeutics raised $40M (Series A) on November 8, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Actym Therapeutics raised $60M (Series A) on October 18, 2023.
Who to call at On Target Laboratories, and when
A new round usually means On Target Laboratories is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day On Target Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at On Target Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at On Target Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment On Target Laboratories raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
On Target Laboratories raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.